Because hypoglycemia can be associated with greater inpatient mortality, the basal-bolus insulin treatment approach can provide the best balance between controlling hyperglycemia while decreasing the risk of hypoglycemia [22]. This evidence concerns the gene INS and Hypoglycemia.